Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$15.26 - $23.75 $488,320 - $760,000
-32,000 Reduced 15.09%
180,000 $4.18 Million
Q4 2022

Feb 14, 2023

BUY
$14.51 - $20.99 $377,260 - $545,740
26,000 Added 13.98%
212,000 $3.08 Million
Q3 2022

Nov 14, 2022

SELL
$18.21 - $27.88 $637,350 - $975,800
-35,000 Reduced 15.84%
186,000 $3.55 Million
Q2 2022

Aug 15, 2022

BUY
$16.45 - $25.88 $1.75 Million - $2.75 Million
106,290 Added 92.66%
221,000 $4.02 Million
Q1 2022

May 16, 2022

SELL
$22.67 - $28.01 $1.71 Million - $2.11 Million
-75,290 Reduced 39.63%
114,710 $2.89 Million
Q4 2021

Feb 14, 2022

BUY
$24.13 - $32.63 $772,160 - $1.04 Million
32,000 Added 20.25%
190,000 $5.24 Million
Q3 2021

Nov 17, 2021

SELL
$29.97 - $36.66 $959,040 - $1.17 Million
-32,000 Reduced 16.84%
158,000 $5.1 Million
Q3 2021

Nov 15, 2021

BUY
$29.97 - $36.66 $562,177 - $687,668
18,758 Added 10.95%
190,000 $5.69 Million
Q2 2021

Aug 13, 2021

SELL
$25.39 - $32.61 $13,786 - $17,707
-543 Reduced 0.32%
171,242 $5.24 Million
Q1 2021

May 06, 2021

SELL
$19.92 - $31.6 $933,550 - $1.48 Million
-46,865 Reduced 21.43%
171,785 $5.23 Million
Q4 2020

Feb 16, 2021

BUY
$12.16 - $19.77 $2.66 Million - $4.32 Million
218,650 New
218,650 $4.32 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.01B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.